Abbott

By Jonah Comstock September 13, 2017
Today was a big day in the world of diabetes management technology, with major announcements from Abbott, Livongo, and Senseonics. Read on below for a round-up of diabetes news. Livongo acquires Diabeto Mountain View, California-based Livongo Health, the chronic condition management technology company founded by former Allscripts CEO Glen Tullman, has acquired Diabeto, a diabetes management...
By Jonah Comstock July 19, 2017
Oscar Health is working with Humana to offer commercial health insurance to small businesses in a nine-county Nashville, Tenn. area. Tech-saavy insurance startup Oscar is teaming up with incumbent Humana at a time when it’s just begun to expand from the individual market into working with employers through its Oscar for Business unit. Humana will provide licenses to operate in Nashville as well...
By Jeff Lagasse July 17, 2017
Abbott and Bigfoot Biomedical have entered into an agreement to develop and commercialize diabetes management systems, integrating Abbott's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions.    Under the agreement, Abbott will supply glucose measurement sensors for all of Bigfoot's insulin delivery systems in the U.S. as the exclusive sensors for those systems...
By Jonah Comstock February 15, 2017
Abbott Diabetes Care shared some real-world evidence this morning at the International Conference on Advanced Technologies & Treatments for Diabetes, bolstering clinical trial data about the effectiveness of the company's Freestyle Libre device line. "We’re certainly committed to sharing as much information as is possible with our users and our health providers in order to be able to make...
By Heather Mack October 7, 2016
As we take a look at the devices that received FDA clearance in 2016's third quarter, we're also considering that the last few months have been a time of change at the Food and Drug Administration, as regulators are beginning to make updates in their system to accomodate all the digital health tools we're seeing.  In June, the FDA offered up a draft guidance document designed to help medical...
By Jonah Comstock September 28, 2016
Abbott has received FDA Clearance for its FreeStyle Libre Pro system, a key milestone in bringing the company's unique take on the continuous glucose monitor to the United States. In Europe, where the system has had CE Mark clearance since September 2014, there is both a prescription and over-the-counter version available and the latter is smartphone compatible. "FreeStyle Libre Pro transforms...
By Jonah Comstock September 15, 2016
Austria and San Diego-based mySugr has added coaching to the premium version of its mySugr Logbook app, the company announced this week.  "What we want to do is create a digital diabetes clinic," North American Managing Director Kyle J. Rose said today at the Digital Medicine Connect event in Boston. "What we’ve decided to do is actually work with diabetes educators as coaches. Because, as...
By Jonah Comstock October 27, 2014
Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren't seeing downloads and usage on par with the apps from other industries. That's the conclusion of a new report from Research2Guidance (R2G), which analyzed more than 725 apps from 11 pharma companies. According to R2G, the top pharma companies have 65 apps in the Apple and...
By Jonah Comstock August 18, 2014
Welkin Health's iOS app. Digital health accelerator Rock Health announced this week that it has added a half dozen new startups, along with three new corporate partners that will support portfolio companies through mentorship and other forms of guidance. Rock Health companies receive a $100,000 in investment and a variety of other perks during their stay in the program, including support from...
By Brian Dolan March 13, 2014
Baltimore, Maryland-based WellDoc, one of the earliest and best known mobile health companies focused on diabetes management, has appointed Kevin McRaith as the company's new president. McRaith most recently served as VP of Sales & Marketing at Human Genome Sciences, and previously worked at Genentech, Abbott and Baxter. In this role McRaith will report to WellDoc CEO Ryan Sysko. WellDoc's...